益智仁盐炙“缩尿”作用的研究
|
摘要
益智为姜科山姜属植物益智Alpinia oxyphylla Miq.的干燥成熟果实,药用部位为种仁。生品辛温而燥,主要归脾经,以温脾止泻、收摄涎唾力胜,多用于腹痛吐泻、口涎自流;盐炙可缓和辛燥之性,主要归肾经,专行下焦,长于固精、缩尿,用于肾气虚寒的遗精、早泄、尿频、遗尿。
目的
本课题在国家科技部十一五支撑计划“炮制共性技术—盐炙法”的支持下,选用临床疗效确切的中药益智仁为研究对象,以益智仁盐炙前后功效和临床应用迥异为切入点,拟初步阐明盐益智仁“缩尿”作用的机理和物质基础,进而解释益智仁“盐制入肾—缩尿”理论的科学内涵,并为研究盐制共性技术的其它药物提供一种思路。
方法
重点观察益智仁盐炙前后的“缩尿”作用有无差异,采用药效学和化学结合的手段开展研究。
1.在尿频、尿多动物模型的国内外研究现状基础上,研究小鼠代谢笼,对三种尿频、尿多动物模型进行制作与观察。
2.在固定药材来源、饮片炮制方法的基础上,研究益智仁生品和盐炙品的急性毒性和对正常及水负荷小鼠尿量影响,研究盐益智仁“缩尿”作用的关键因素。
3.“缩尿”作用机理研究:建立小鼠水负荷尿多模型,进行尿液电解质含量、血浆醛固酮含量、血浆抗利尿激素含量测定;并开展对离体膀胱平滑肌活动影响的实验研究。
4.“缩尿”作用物质基础研究:对益智仁生品和盐炙品的化学成分进行预试验研究;对盐益智仁“缩尿”有效浸出物进行筛选和制备,研究该有效浸出物的急性毒性和量效关系;对有效浸出物进行化学成分预试验、总萜类含量测定和GC-MS分析,并用指纹图谱技术控制有效浸出物质量;对盐益智仁中食盐含量限度进行研究。
结果
1.研制出适合小鼠尿液收集的代谢笼(已申请专利),建立了稳定、可控的小鼠水负荷尿多模型。
2.急性毒性试验,益智仁生品和盐炙品对小鼠的最大给药量为临床成人用量的924.4倍和888.8倍。
3.益智仁生品和盐炙品在成人用量80倍时,均可显著降低正常小鼠尿量。对于水负荷小鼠尿多模型,益智仁盐炙品起效的关键因素在于药物本身,但食盐起到协同增效作用;益智仁生品用量在成人日服剂量120倍起效,而盐炙品用量在成人日服剂量80倍即可起效。
4.益智仁生品可显著降低水负荷小鼠血浆醛固酮浓度,具有保钠排钾的作用,但盐炙后该作用却降低;盐炙品能显著增加水负荷小鼠血浆抗利尿激素浓度;生品和盐炙品均随剂量增大而拮抗乙酰胆碱引起的豚鼠离体膀胱平滑肌兴奋,且盐炙后效果增强。
5.盐益智仁“缩尿”作用物质基础是“75%醇-石油醚浸出物+食盐”,该浸出物的LD_(50)为成人日服剂量的378倍,具有一定的神经毒性,起效剂量为临床成人日服剂量的100倍;暂定75%醇-石油醚浸出物中总萜类成分以努特卡酮(Nootkatone)计,不得少于15.1%;建立该有效浸出物的指纹图谱,并用GC-MS技术鉴定出其中的16个化学成分;暂定盐益智仁中食盐含量限度以氯离子(Cl~-)计为1.5%～1.8%。
结论
益智仁盐炙前后的“缩尿”作用具有明显的差异,小鼠实验中生品的起效剂量为临床成人日服剂量的120倍,而盐炙后可将起效剂量降低到80倍,说明益智仁临床用于治疗尿频、尿多疾病需盐炙的科学合理性,也初步证明了益智仁“盐制入肾·缩尿”中医药理论的正确性。盐益智仁的“缩尿”作用是药物和食盐协同增效的结果,其物质基础为“益智仁75%醇-石油醚浸出物+食盐”;其“缩尿”作用的机理在于增加抗利尿激素的分泌而增加水液的重吸收,以及产生类似M受体抑制剂的作用,作用于膀胱平滑肌的M受体,降低膀胱平滑肌的收缩。
创新点
1.研究辅料食盐与益智仁的相关性,初步阐明两者在“缩尿”方面的协同增效作用,为“盐制入肾”的炮制理论找到一定的科学依据。
2.初步阐明盐益智仁“缩尿”作用的物质基础和机理。
3.设计创制了小鼠代谢笼(收集尿液的装置),并申请实用新型专利。
Alpiniae Oxyphyllae(Alpinia Roxb,Zingiberaceae) is the dry ripe fruit of Alpinia oxyphylla Miq.with kernal as its medicinal part.The crude Alpiniae Oxyphyllae Fructus(CAOF) is pungent in flavour,warm and dry in property,acting on the pleen channel,and good at wanning the pleen and stopping diarrhea,astringing and preserving the droll-spittle,usually being used to treat abdominal pain,vomiting and diarrhoea,uncontrollable drolling.The stir-heated Alpiniae Oxyphyllae Fructus (SAOF) with salt soltuion can moderate the pungent,warm property,act on the kidney channel and the lower jiao exclusively,and specialize in conserving essence and arresting polyuria,usually being used for emissions,premature ejaculation, frequent mieturition and enuresis resulted from kidney qi deficiency cold.
Aims:
Being a branch of "technical commonness in the processing medthod of stir-heating with salt solution"under the State Ministry of Science and Technology 11th Five-Year Plan Support,our study aimed at the traditioanl medicinal herb Alpiniae OxyphyUae Fructus having affirmative clinical therapeutic effect,focused on the differences between the effects and clinical applications respectively before and after processing,expecting to elucidate the mechnism and active components for the arresting polyuria effect of SAOF,further interpreting the scientific connotation of the theory for "The stir-heated drug with salt solution acts on kidney,and the arresting polyuria effect",and then providing a new idea for the investigations on the drags processed by common techniques in stir-heating with salt solution.
Methods:
The differences in the arresting polyuria effect of Alpiniae Oxyphyllae Fructus before and after stir-heating with salt solution were focused by both of pharmacodynamical and chemical means.
1.According to the present study situations of the animal models of frequent micturition and polyurine at home and abroad,the mouse metabolic cage was employed to perform empirical study of three types of animal models of frequent micturition and polyurine.
2.With the fixed herbal sources and fixed processing methods,the acute toxicity and the influences on the noraml and water-loading mouse of CAOF and SAOF were studied,and the crucial factors of SAOF for arresting polyuria were investigated.
3.In the course of urine production,using water-loading mouse model of polyurine as the study object,the mechanism was investigated through the quantification of electrolyte,plasma aldosterone and plasma antidiuretic hormone;in the course of urine excretion,the mechnism was investigated on the effects on the ex vivo detrusor of bladder.
4.Prelimianry tests were carried out to study the chemical compositions of CAOF and SAOF.The acitve fraction with the arresting polyuria effect of SAOF was screened and prepared,of which the acute toxicity and dose-effect relationship were studied.The initial investigations were carried out on the chemicial compositions of that fraction,such as the prelimianry tests,assaying of total terpenoid and G-C-MS analysis. The salt content limitation of SAOF was considered as well.
Results:
1.The metabolic cage suitable for the mouse urine collection was prepared,and the stable and controllable water-loading mouse model for polyurine was developed.
2.The maximum dosages of CAOF and SAOF for the acute-term toxicity test were 924.4 times and 888.8 times of the clinical adult dosage,respectively.
3.With 80 times adult dosage,both of them showed the ability to reduce the urinary volume of normal mouse significantly;for the water-loading mouse model of polyurine,the crucial working substance of SAOF was the drug itself,and the salt played a synergistic role.CAOF took effect at 120 times adult dosage,while SAOF at 80 times.
4.CAOF significantly reduced the plasma aldosterone concentration of water-loading mouse and showed the effect of guaranteeing a sodium row of potassium,whereas this effect decreased after stir-heaing with salt solution;SAOF significantly increased the plasma aldosterone concentration of water-loading mouse; both of CAOF and SAOF stimulated the ex vivo bladder of Cavia procellus via acetylcholine antagonism with an increasing dosage,and SAOF showed a stronger effect.
5.The acitve components of SAOF for arresting polyuria were"petroleum benzine fraction + salt",namely active group.With LD_(50) of 375 times adult dosage this group showed some neurotoxicity;the working dosage is 100 times adult daytime dosage.The limitation of total terpenoid was not less than 15.1%referenced to Nootkatone in petroleum benzine fraction,and to establish the chromatographic fingerprint.16 chemical compositions of petroleum benzine fraction were identified using GC-MS.The limitation of salt content was tentatively set as 1.5%-1.8% referenced to chioridion.
Conclusions:
The effect of arresting polyuria of Alpiniae Oxyphyllae Fructus before and after stir-heating with salt solution are evidently different.The working dosage of CAOF was 120 times adult dosage while that of SAOF was 80 times,which indicates the rationality of the clinical applications of SAOF in the treatment of frequent urination and polyurine,intiaUy proving the TCM theory for "Stir-heating drug with salt solution acts on kidney channel,and kidney governs water".The effect of arresting urtrination of Alpiniae Oxyphyllae Fructus after stir-heating with salt solution attributes to the synergistic actions of the drug and salt,with "petroleum benzine fraction of Alpiniae Oxyphyllae Fructus + salt"as the active components.The action mechnism lies in the increased water reabsorption due to the increased ntidiuretic hormon secretion and its influence on the M-receptor of bladder smooth muscle as M-receptor inhibitor thus decreasing the construction of bladder smooth muscle.
Innovations:
1.Elucidating the synergistic actions of Alpiniae OxyphyUae Fructus and salt for arresting polyuria initially,such can certify the theory about "the stir-heated drug with salt solution acts on kidney,and the arresting polyuria effect".
2.Elucidating the active components and mechnisms for arresting polyuria initially.
3.Developing the water-loading mouse model for polyurine,and applying for patent of utility model.
目的
本课题在国家科技部十一五支撑计划“炮制共性技术—盐炙法”的支持下,选用临床疗效确切的中药益智仁为研究对象,以益智仁盐炙前后功效和临床应用迥异为切入点,拟初步阐明盐益智仁“缩尿”作用的机理和物质基础,进而解释益智仁“盐制入肾—缩尿”理论的科学内涵,并为研究盐制共性技术的其它药物提供一种思路。
方法
重点观察益智仁盐炙前后的“缩尿”作用有无差异,采用药效学和化学结合的手段开展研究。
1.在尿频、尿多动物模型的国内外研究现状基础上,研究小鼠代谢笼,对三种尿频、尿多动物模型进行制作与观察。
2.在固定药材来源、饮片炮制方法的基础上,研究益智仁生品和盐炙品的急性毒性和对正常及水负荷小鼠尿量影响,研究盐益智仁“缩尿”作用的关键因素。
3.“缩尿”作用机理研究:建立小鼠水负荷尿多模型,进行尿液电解质含量、血浆醛固酮含量、血浆抗利尿激素含量测定;并开展对离体膀胱平滑肌活动影响的实验研究。
4.“缩尿”作用物质基础研究:对益智仁生品和盐炙品的化学成分进行预试验研究;对盐益智仁“缩尿”有效浸出物进行筛选和制备,研究该有效浸出物的急性毒性和量效关系;对有效浸出物进行化学成分预试验、总萜类含量测定和GC-MS分析,并用指纹图谱技术控制有效浸出物质量;对盐益智仁中食盐含量限度进行研究。
结果
1.研制出适合小鼠尿液收集的代谢笼(已申请专利),建立了稳定、可控的小鼠水负荷尿多模型。
2.急性毒性试验,益智仁生品和盐炙品对小鼠的最大给药量为临床成人用量的924.4倍和888.8倍。
3.益智仁生品和盐炙品在成人用量80倍时,均可显著降低正常小鼠尿量。对于水负荷小鼠尿多模型,益智仁盐炙品起效的关键因素在于药物本身,但食盐起到协同增效作用;益智仁生品用量在成人日服剂量120倍起效,而盐炙品用量在成人日服剂量80倍即可起效。
4.益智仁生品可显著降低水负荷小鼠血浆醛固酮浓度,具有保钠排钾的作用,但盐炙后该作用却降低;盐炙品能显著增加水负荷小鼠血浆抗利尿激素浓度;生品和盐炙品均随剂量增大而拮抗乙酰胆碱引起的豚鼠离体膀胱平滑肌兴奋,且盐炙后效果增强。
5.盐益智仁“缩尿”作用物质基础是“75%醇-石油醚浸出物+食盐”,该浸出物的LD_(50)为成人日服剂量的378倍,具有一定的神经毒性,起效剂量为临床成人日服剂量的100倍;暂定75%醇-石油醚浸出物中总萜类成分以努特卡酮(Nootkatone)计,不得少于15.1%;建立该有效浸出物的指纹图谱,并用GC-MS技术鉴定出其中的16个化学成分;暂定盐益智仁中食盐含量限度以氯离子(Cl~-)计为1.5%～1.8%。
结论
益智仁盐炙前后的“缩尿”作用具有明显的差异,小鼠实验中生品的起效剂量为临床成人日服剂量的120倍,而盐炙后可将起效剂量降低到80倍,说明益智仁临床用于治疗尿频、尿多疾病需盐炙的科学合理性,也初步证明了益智仁“盐制入肾·缩尿”中医药理论的正确性。盐益智仁的“缩尿”作用是药物和食盐协同增效的结果,其物质基础为“益智仁75%醇-石油醚浸出物+食盐”;其“缩尿”作用的机理在于增加抗利尿激素的分泌而增加水液的重吸收,以及产生类似M受体抑制剂的作用,作用于膀胱平滑肌的M受体,降低膀胱平滑肌的收缩。
创新点
1.研究辅料食盐与益智仁的相关性,初步阐明两者在“缩尿”方面的协同增效作用,为“盐制入肾”的炮制理论找到一定的科学依据。
2.初步阐明盐益智仁“缩尿”作用的物质基础和机理。
3.设计创制了小鼠代谢笼(收集尿液的装置),并申请实用新型专利。
Alpiniae Oxyphyllae(Alpinia Roxb,Zingiberaceae) is the dry ripe fruit of Alpinia oxyphylla Miq.with kernal as its medicinal part.The crude Alpiniae Oxyphyllae Fructus(CAOF) is pungent in flavour,warm and dry in property,acting on the pleen channel,and good at wanning the pleen and stopping diarrhea,astringing and preserving the droll-spittle,usually being used to treat abdominal pain,vomiting and diarrhoea,uncontrollable drolling.The stir-heated Alpiniae Oxyphyllae Fructus (SAOF) with salt soltuion can moderate the pungent,warm property,act on the kidney channel and the lower jiao exclusively,and specialize in conserving essence and arresting polyuria,usually being used for emissions,premature ejaculation, frequent mieturition and enuresis resulted from kidney qi deficiency cold.
Aims:
Being a branch of "technical commonness in the processing medthod of stir-heating with salt solution"under the State Ministry of Science and Technology 11th Five-Year Plan Support,our study aimed at the traditioanl medicinal herb Alpiniae OxyphyUae Fructus having affirmative clinical therapeutic effect,focused on the differences between the effects and clinical applications respectively before and after processing,expecting to elucidate the mechnism and active components for the arresting polyuria effect of SAOF,further interpreting the scientific connotation of the theory for "The stir-heated drug with salt solution acts on kidney,and the arresting polyuria effect",and then providing a new idea for the investigations on the drags processed by common techniques in stir-heating with salt solution.
Methods:
The differences in the arresting polyuria effect of Alpiniae Oxyphyllae Fructus before and after stir-heating with salt solution were focused by both of pharmacodynamical and chemical means.
1.According to the present study situations of the animal models of frequent micturition and polyurine at home and abroad,the mouse metabolic cage was employed to perform empirical study of three types of animal models of frequent micturition and polyurine.
2.With the fixed herbal sources and fixed processing methods,the acute toxicity and the influences on the noraml and water-loading mouse of CAOF and SAOF were studied,and the crucial factors of SAOF for arresting polyuria were investigated.
3.In the course of urine production,using water-loading mouse model of polyurine as the study object,the mechanism was investigated through the quantification of electrolyte,plasma aldosterone and plasma antidiuretic hormone;in the course of urine excretion,the mechnism was investigated on the effects on the ex vivo detrusor of bladder.
4.Prelimianry tests were carried out to study the chemical compositions of CAOF and SAOF.The acitve fraction with the arresting polyuria effect of SAOF was screened and prepared,of which the acute toxicity and dose-effect relationship were studied.The initial investigations were carried out on the chemicial compositions of that fraction,such as the prelimianry tests,assaying of total terpenoid and G-C-MS analysis. The salt content limitation of SAOF was considered as well.
Results:
1.The metabolic cage suitable for the mouse urine collection was prepared,and the stable and controllable water-loading mouse model for polyurine was developed.
2.The maximum dosages of CAOF and SAOF for the acute-term toxicity test were 924.4 times and 888.8 times of the clinical adult dosage,respectively.
3.With 80 times adult dosage,both of them showed the ability to reduce the urinary volume of normal mouse significantly;for the water-loading mouse model of polyurine,the crucial working substance of SAOF was the drug itself,and the salt played a synergistic role.CAOF took effect at 120 times adult dosage,while SAOF at 80 times.
4.CAOF significantly reduced the plasma aldosterone concentration of water-loading mouse and showed the effect of guaranteeing a sodium row of potassium,whereas this effect decreased after stir-heaing with salt solution;SAOF significantly increased the plasma aldosterone concentration of water-loading mouse; both of CAOF and SAOF stimulated the ex vivo bladder of Cavia procellus via acetylcholine antagonism with an increasing dosage,and SAOF showed a stronger effect.
5.The acitve components of SAOF for arresting polyuria were"petroleum benzine fraction + salt",namely active group.With LD_(50) of 375 times adult dosage this group showed some neurotoxicity;the working dosage is 100 times adult daytime dosage.The limitation of total terpenoid was not less than 15.1%referenced to Nootkatone in petroleum benzine fraction,and to establish the chromatographic fingerprint.16 chemical compositions of petroleum benzine fraction were identified using GC-MS.The limitation of salt content was tentatively set as 1.5%-1.8% referenced to chioridion.
Conclusions:
The effect of arresting polyuria of Alpiniae Oxyphyllae Fructus before and after stir-heating with salt solution are evidently different.The working dosage of CAOF was 120 times adult dosage while that of SAOF was 80 times,which indicates the rationality of the clinical applications of SAOF in the treatment of frequent urination and polyurine,intiaUy proving the TCM theory for "Stir-heating drug with salt solution acts on kidney channel,and kidney governs water".The effect of arresting urtrination of Alpiniae Oxyphyllae Fructus after stir-heating with salt solution attributes to the synergistic actions of the drug and salt,with "petroleum benzine fraction of Alpiniae Oxyphyllae Fructus + salt"as the active components.The action mechnism lies in the increased water reabsorption due to the increased ntidiuretic hormon secretion and its influence on the M-receptor of bladder smooth muscle as M-receptor inhibitor thus decreasing the construction of bladder smooth muscle.
Innovations:
1.Elucidating the synergistic actions of Alpiniae OxyphyUae Fructus and salt for arresting polyuria initially,such can certify the theory about "the stir-heated drug with salt solution acts on kidney,and the arresting polyuria effect".
2.Elucidating the active components and mechnisms for arresting polyuria initially.
3.Developing the water-loading mouse model for polyurine,and applying for patent of utility model.
引文
[1](南北朝)雷敩撰,(清)张骥补辑,施仲安校注.雷公炮炙论[M].南京:江苏科学技术出版社,1985:75-75.
[2]张春玲,王晓军.食盐及盐炙法在中药炮制中的应用[J].甘肃中医学院学报.2003,20(4):46-47.
[3]吕文海,冯宝麟.从中药盐炙沿革看盐炙的作用及原意[J].中国中药杂志.1990,15(1):23-26.
[4](明)陈嘉谟撰.本草蒙筌[M].北京:人民卫生出版社.1988:5-5.
[5](明)李梃撰.医学入门[M].江西:江西科学技术出版社.1988:271-271.
[6](宋)齐仲甫撰,宋咏梅等点校.女科百问[M].天津:天津科学技术出版社,1999:70-70.
[7](元)危亦林撰,王育学等校注.世医得效方[M].北京:中国中医药出版社,1996.
[8](明)朱棣.普济方[M].北京:人民卫生出版社,1959.
[9](明)李时珍撰.本草纲目(校点本第二册)[M].北京:人民卫生出版社,1977:870-872.
[10](明)宋林皋撰,秦伯未校.宋氏女科秘书[M].上海:中医书局,1955.
[11](明)李中梓撰,王卫等点校.医宗必读[M].天津:天津科学技术出版社,1999:103-103.
[12](明)龚廷贤撰,袁钟点校.寿世保元[M].大连:辽宁科学技术出版社,1997:153-153.
[13](宋)卢多逊撰,尚志钧辑校.开宝本草[M].合肥:安徽科学技术出版社,1998:302-302.
[14](元)王好古撰,崔扫尘等辑校.汤液本草[M].北京:人民卫生出版社,1987:133-134.
[15](金)张元素撰,任应秋点校.医学启源[M].北京:人民卫生出版社,1978:182-182.
[16](清)太医院撰,李顺宝校注.药性通考[M].北京:学苑出版社,2006:349-349.
[17](清)张秉成撰.本草便读[M].上海:上海卫生出版社,1957:42-43.
[18](唐)陈藏器撰,尚志钧辑释.《本草拾遗》辑释[M].合肥:安徽科学技术出版社,2002:165-165.
[19](明)李时珍撰.本草纲目(校点本第一册)[M].北京:人民卫生出版社,1977:711-712.
[20](清)汪昂撰.本草备要[M].北京:中国中医药出版社,1998:111-112.
[21](清)黄宫绣撰.本草求真[M].上海:上海科学技术出版社,1959:113-113.
[22](明)缪希雍撰,郑金生校注.神农本草经疏[M].北京:中医古籍出版社,2002:537-538.
[23](清)张璐撰,赵小青等校注.本经逢原[M].北京:中国中医药出版社,1996:63-63.
[24](清)杨时泰撰.本草述钩元[M].上海:科技卫生出版社,1958:176-177.
[25]徐叔云,卞如濂,陈修.药理实验方法学(第三版)[M].北京:人民卫生出版社,2002:1223-1225.
[26]黄崇刚,刘剑毅,宋国红,等.舒安冲剂对动物多尿模型的作用[J].重庆中草药研究,2005(1):65-65.
[27]郝美荣,胥云.利尿灵的利尿药理学研究[J].中国中药杂志,1997,22(12):747-750.
[28]邝安堃,吴裕圻,丁霆,等.某些助阳药对于大剂量皮质素所致耗竭现象的影响[J].中华内科杂志,1963,11(2):113.
[29]陈小野主编.实用中医证候动物模型学[M].北京:北京医科大学,中国协和医科大学联合出版社,1993.101-117.
[30]李春生,张国玺,石体仁,等.山茱萸水溶性总提取物对肾阳虚动物模型生命质量和肾上腺组织的影响[J].中医杂志,2001,42(8):491-493.
[31]彭蕴茹,沈明勤,罗宇慧,等.金匮肾气丸防治小鼠肾阳虚的实验研究[J].中成药,2004,26(5):395-397.
[32]施雪筠主编.生理学[M].北京:中国中医药出版社,2005.207-238.
[33]施文荣,刘艳,陈玲,等.白术燥湿利水作用的研究[J].福建中医学院学报,2007,17(3):29-31.
[34]吴清和,李育浩.缩泉丸的药理学研究[J].新中医,1991,23(12):49-50,37.
[35]许实波,彭汶铎.柳珊瑚酸的抗利尿作用[J].中山大学学报论丛,1994(06):1-3.
[36]江明性主编.药理学[M].北京:人民卫生出版社,2000:197-197.
[37]王德山,李秋莲主编.生理学·生物化学[M].上海:上海中医药大学出版社,2001.493-500.
[38]张春旭,王伟祥,高锋.酶法、化学法与电极法测定血清电解质的方法学对比与评估[J]..检验医学,2004,19(3):256-257.
[39]邢喜龙,宋丽芳,张理华.血清K、Na、Cl在生化分析仪上的应用及评价[J].实用医技杂志,2006,13(13):2275-2275.
[40]李立人,戴耀宗,刘久敏.测定醛固酮浓度/肾素活性(SAC/PRA)值在原发性醛周酮增多症中的临床意义[J].放射免疫学杂志,2003,16(2):71-72.
[41]梅仁彪,李颍.高血压矿工血浆醛固酮表达水平的分析[J].现代预防医学,2007,34(3):424-426.
[42]惠觅宙,史轶蘩.人血浆抗利尿激素的生理及临床初步研究[J].中华内分泌代谢杂志.1989,5(4):204-206.
[43]李果,陈家伦.抗利尿激素研究的若干进展[J].基础医学与临床,1990,10(3):149-155.
[44]汪静雪.抗利尿激素及其分泌的调节[J].生物学教学,2003,28(9):47-48.
[45]惠觅宙,周学瀛.人血浆抗利尿激素放射免疫分析法[J].中国医学科学院学报,1990,12(5):370-374.
[46]杨俊,黄祖汉.抗利尿激素放射免疫分析药盒的研制及临床应用[J].第一军医大学学报.1992,12(3):246-248.
[47]黄秀深,刘德芳,等.大鼠中焦湿阻证与抗利尿激素关系的实验研究[J].成都中医药大学学报,2002,25(1):35-35,37.
[48]Callewaere C,Banisadr G,Desarmenien MG,et al.The chemokine SDF-1/CXCL12modulates the firing pattern of vasopressin neurons and counteracts induced vasopressin release through CXCR4[J].Proc Natl Acad Sci USA,2006,103(21):8221-8226.
[49]张英福,邱小青.乌梅对豚鼠膀胱逼尿肌运动影响的实验研究[J].山西中医,2000,16(2):43-45.
[50]曾俊伟,余梅,骆亚莉,等.大黄对豚鼠离体膀胱逼尿肌条收缩活动影响的实验研究[J],中药药理与临床,2005,21(1):27-29.
[51]王富军,胡钢.膀胱过度活动症的研究进展[J].现代诊断与治疗,2007,18(2):103-105,109.
[52]杨欣.膀胱过度活动症的诊断与治疗[J].中国实用妇科与产科杂志,2007,23(11):894-896.
[53]冯淑香,刘耀明,董俊兴.中药益智仁化学成分与药理研究进展[J].现代中药研究与实践,2003,17(5):58-61.
[54]詹若挺.高良姜、益智规范化栽培技术[M].广州:广东科技出版社,2003.38-39.
[55]国家药典委员会编.中华人民共和国药典2005年版一部[M].北京:化学工业出版社.2005.204-205.
[56]谭睿,陈士林,杨大坚.GC-MS分析益智挥发油透大鼠血脑屏障的成分研究[J].中草药,2004,35(6):624-625.
[57]GB 5461-2000食用盐[S].
[58]GB/T 13025.6-1991制盐工业通用实验方法氯离子的测定[S].
[59]吴育良,周志航.用氯离子选择电极同时分析水中Cl~-、Br~-、I~-的含量[J].分析试验室.1994,13(4):56-58.
[60]王卫星,郭朝晖,张玉萍.饮用水中氯化物的氯离子选择电极测定法[J].环境与健康杂志,2003,20(3):172-173.
[1]中医研究院中药研究所.历代中药炮制资料辑要[M].北京:内部出版,1973.
[2]王孝涛.关于对中药炮制历史沿革研究的看法[J].中国中药杂志,1992,17(4):211-212.
[3](唐)蔺道人.仙授理伤续断秘方[M].北京:人民卫生出版社,1957.
[4](宋)王怀隐,陈昭遇,等.太平圣惠方(上、下册)[M].北京:人民卫生出版社,1958.
[5](宋)洪遵著,宋咏梅等点校.洪氏集验方[M].上海:上海科学技术出版社,2003.
[6](宋)齐仲甫著,宋咏梅等点校.女科百问[M].天津:天津科学技术出版社,1999.
[7](宋)许叔微.普济本事方[M].上海:上海科学技术出版社,1959.
[8](元)王好古著,崔扫麈等点校.汤液本草[M].北京:人民卫生出版社,1987.
[9](元)危亦林著,王育学等校注.世医得效方[M].北京:中国中医药出版社,1996.
[10](元)罗天益.卫生宝鉴[M].北京:人民卫生出版社,1987.
[11](明)陈嘉谟.本草蒙筌[M].北京:人民卫生出版社,1988.
[12](明)朱棣.普济方[M].北京:人民卫生出版社,1959.
[13](明)刘文泰.本草品汇精要[M].北京:人民卫生出版社,1982.
[14](明)缪希雍.炮炙大法[M].北京:人民卫生出版社,1956.
[15](明)董宿辑录,(明)方贤续补,可嘉校注.奇效良方[M].北京:中国中医药出版社,1995.
[16](明)戴原礼著,才维秋等校注.秘传证治要诀及类方[M].北京:中国中医药出版社,1998.
[17](明)王肯堂著,吴唯等校注.证治准绳[M].北京:中国中医药出版社,1997.
[18](明)李时珍著,张守康等主校.本草纲目[M].北京:中国中医药出版社,1998.
[19](明)宋林皋.宋氏女科秘书[M].北京:中医书局,1955.
[20](明)李中梓著,王卫等点校.医宗必读[砌.天津:天津科学技术出版社,1999.
[21](明)龚廷贤撰,袁钟点校.寿世保元[M].大连:辽宁科学技术出版社,1997.
[22](明)王节斋集,薛已注.明医杂录[M].上海:大成书局《薛氏医案》石印本,1922.
[23](明)张浩.仁术便览[M].北京:商务印书馆,1957.
[24](明)张介宾.景岳全书[M].北京:中国中医药出版社,1994.
[25](明)武之望著,李明廉主校.济阴纲目[M].北京:人民卫生出版社,1996.
[26](清)陈修园.女科要旨[M].北京:人民卫生出版社,1982.
[27](清)蒋示吉著,王道瑞等校.医宗说约[M].北京:中国中医药出版社,2004.
[28](清)刘若金.本草述[M].北京:北京出版社,2000.
[29](清)杨时泰.本草述钩元[M].北京:科技卫生出版社,1958.
[30](清)黄元御著,麻瑞亭等点校.黄元御医书十一种--玉楸药解[M].北京:人民卫生出版社,1990.
[31](清)郭佩兰.本草汇[M].北京:北京出版社,2000.
[32](清)姚球.本草经解要[M].上海:上海古籍出版社,1996.
[33](清)陈复正著,图娅点校.幼幼集成[M].大连:辽宁科学技术出版社,1997.
[34](清)吴仪洛著,朱建平等点校.本草从新[M].北京:中医古籍出版社,2001.
[35](清)严西亭等著.得配本草[M].上海:上海科学技术出版社,1958.
[36](清)凌奂.本草害利[M].北京:中医古籍出版社,1982.
[37](清)张璐.本经逢原[M].北京:中国中医药出版社,2007.
[38](清)黄宫绣.本草求真[M].北京:人民卫生出版社,1987.
[39](清)汪昂著,张莉莎点校.医方集解[M].大连:辽宁科学技术出版社,1997.
[40](清)吴瑭著,李宗一等校注.吴鞠通医案[M].北京:中国中医药出版社,1998.
[41]中华人民共和国卫生部药典委员会.中华人民共和国药典1963年版一部[M].北京:人民卫生出版社,1964.
[42]中华人民共和国卫生部药典委员会.中华人民共和国药典一九七七年版一部[M].北京:人民卫生出版社,1978.
[43]中华人民共和国卫生部药典委员会.中华人民共和国药典一九八五年版一部[M].北京:人民卫生出版社、化学工业出版社,1985.
[44]中华人民共和国药政管理局.全国中药炮制规范1988年版[M].北京:人民卫生出版社, 1988.
[45]山东省卫生厅.山东省中药炮制规范一九九0年版[M].济南:山东科学技术出版社,1991.
[46]江西省卫生厅药政管理局.江西省中药炮制规范1991年版[M].上海:上海科学技术出版社,1991.
[47]吉林省卫生厅编.吉林省中药炮制标准(1986)[M].长春:吉林科学技术出版社出版。1987.
[48]庞国兴,金传山,江黎,等.益智炮制的初步研究[J].中成药.1994,16(5):21-22.
[49]张宏扬,益智取仁的新方法[J].中成药.1985,7:47-47.
[50]赵士凯.黄有云.益智仁的传统炮制及其工艺选择[J].中成药.1994,16(3);24-25.
[51]李贞汉,蔡月英.益智仁炮制新法[J].福建中医药.1995,26(4):24-24.
[52]刘赞清.益智仁去壳新法[J]。中药材.1990,13(12):48-49.
[2]张春玲,王晓军.食盐及盐炙法在中药炮制中的应用[J].甘肃中医学院学报.2003,20(4):46-47.
[3]吕文海,冯宝麟.从中药盐炙沿革看盐炙的作用及原意[J].中国中药杂志.1990,15(1):23-26.
[4](明)陈嘉谟撰.本草蒙筌[M].北京:人民卫生出版社.1988:5-5.
[5](明)李梃撰.医学入门[M].江西:江西科学技术出版社.1988:271-271.
[6](宋)齐仲甫撰,宋咏梅等点校.女科百问[M].天津:天津科学技术出版社,1999:70-70.
[7](元)危亦林撰,王育学等校注.世医得效方[M].北京:中国中医药出版社,1996.
[8](明)朱棣.普济方[M].北京:人民卫生出版社,1959.
[9](明)李时珍撰.本草纲目(校点本第二册)[M].北京:人民卫生出版社,1977:870-872.
[10](明)宋林皋撰,秦伯未校.宋氏女科秘书[M].上海:中医书局,1955.
[11](明)李中梓撰,王卫等点校.医宗必读[M].天津:天津科学技术出版社,1999:103-103.
[12](明)龚廷贤撰,袁钟点校.寿世保元[M].大连:辽宁科学技术出版社,1997:153-153.
[13](宋)卢多逊撰,尚志钧辑校.开宝本草[M].合肥:安徽科学技术出版社,1998:302-302.
[14](元)王好古撰,崔扫尘等辑校.汤液本草[M].北京:人民卫生出版社,1987:133-134.
[15](金)张元素撰,任应秋点校.医学启源[M].北京:人民卫生出版社,1978:182-182.
[16](清)太医院撰,李顺宝校注.药性通考[M].北京:学苑出版社,2006:349-349.
[17](清)张秉成撰.本草便读[M].上海:上海卫生出版社,1957:42-43.
[18](唐)陈藏器撰,尚志钧辑释.《本草拾遗》辑释[M].合肥:安徽科学技术出版社,2002:165-165.
[19](明)李时珍撰.本草纲目(校点本第一册)[M].北京:人民卫生出版社,1977:711-712.
[20](清)汪昂撰.本草备要[M].北京:中国中医药出版社,1998:111-112.
[21](清)黄宫绣撰.本草求真[M].上海:上海科学技术出版社,1959:113-113.
[22](明)缪希雍撰,郑金生校注.神农本草经疏[M].北京:中医古籍出版社,2002:537-538.
[23](清)张璐撰,赵小青等校注.本经逢原[M].北京:中国中医药出版社,1996:63-63.
[24](清)杨时泰撰.本草述钩元[M].上海:科技卫生出版社,1958:176-177.
[25]徐叔云,卞如濂,陈修.药理实验方法学(第三版)[M].北京:人民卫生出版社,2002:1223-1225.
[26]黄崇刚,刘剑毅,宋国红,等.舒安冲剂对动物多尿模型的作用[J].重庆中草药研究,2005(1):65-65.
[27]郝美荣,胥云.利尿灵的利尿药理学研究[J].中国中药杂志,1997,22(12):747-750.
[28]邝安堃,吴裕圻,丁霆,等.某些助阳药对于大剂量皮质素所致耗竭现象的影响[J].中华内科杂志,1963,11(2):113.
[29]陈小野主编.实用中医证候动物模型学[M].北京:北京医科大学,中国协和医科大学联合出版社,1993.101-117.
[30]李春生,张国玺,石体仁,等.山茱萸水溶性总提取物对肾阳虚动物模型生命质量和肾上腺组织的影响[J].中医杂志,2001,42(8):491-493.
[31]彭蕴茹,沈明勤,罗宇慧,等.金匮肾气丸防治小鼠肾阳虚的实验研究[J].中成药,2004,26(5):395-397.
[32]施雪筠主编.生理学[M].北京:中国中医药出版社,2005.207-238.
[33]施文荣,刘艳,陈玲,等.白术燥湿利水作用的研究[J].福建中医学院学报,2007,17(3):29-31.
[34]吴清和,李育浩.缩泉丸的药理学研究[J].新中医,1991,23(12):49-50,37.
[35]许实波,彭汶铎.柳珊瑚酸的抗利尿作用[J].中山大学学报论丛,1994(06):1-3.
[36]江明性主编.药理学[M].北京:人民卫生出版社,2000:197-197.
[37]王德山,李秋莲主编.生理学·生物化学[M].上海:上海中医药大学出版社,2001.493-500.
[38]张春旭,王伟祥,高锋.酶法、化学法与电极法测定血清电解质的方法学对比与评估[J]..检验医学,2004,19(3):256-257.
[39]邢喜龙,宋丽芳,张理华.血清K、Na、Cl在生化分析仪上的应用及评价[J].实用医技杂志,2006,13(13):2275-2275.
[40]李立人,戴耀宗,刘久敏.测定醛固酮浓度/肾素活性(SAC/PRA)值在原发性醛周酮增多症中的临床意义[J].放射免疫学杂志,2003,16(2):71-72.
[41]梅仁彪,李颍.高血压矿工血浆醛固酮表达水平的分析[J].现代预防医学,2007,34(3):424-426.
[42]惠觅宙,史轶蘩.人血浆抗利尿激素的生理及临床初步研究[J].中华内分泌代谢杂志.1989,5(4):204-206.
[43]李果,陈家伦.抗利尿激素研究的若干进展[J].基础医学与临床,1990,10(3):149-155.
[44]汪静雪.抗利尿激素及其分泌的调节[J].生物学教学,2003,28(9):47-48.
[45]惠觅宙,周学瀛.人血浆抗利尿激素放射免疫分析法[J].中国医学科学院学报,1990,12(5):370-374.
[46]杨俊,黄祖汉.抗利尿激素放射免疫分析药盒的研制及临床应用[J].第一军医大学学报.1992,12(3):246-248.
[47]黄秀深,刘德芳,等.大鼠中焦湿阻证与抗利尿激素关系的实验研究[J].成都中医药大学学报,2002,25(1):35-35,37.
[48]Callewaere C,Banisadr G,Desarmenien MG,et al.The chemokine SDF-1/CXCL12modulates the firing pattern of vasopressin neurons and counteracts induced vasopressin release through CXCR4[J].Proc Natl Acad Sci USA,2006,103(21):8221-8226.
[49]张英福,邱小青.乌梅对豚鼠膀胱逼尿肌运动影响的实验研究[J].山西中医,2000,16(2):43-45.
[50]曾俊伟,余梅,骆亚莉,等.大黄对豚鼠离体膀胱逼尿肌条收缩活动影响的实验研究[J],中药药理与临床,2005,21(1):27-29.
[51]王富军,胡钢.膀胱过度活动症的研究进展[J].现代诊断与治疗,2007,18(2):103-105,109.
[52]杨欣.膀胱过度活动症的诊断与治疗[J].中国实用妇科与产科杂志,2007,23(11):894-896.
[53]冯淑香,刘耀明,董俊兴.中药益智仁化学成分与药理研究进展[J].现代中药研究与实践,2003,17(5):58-61.
[54]詹若挺.高良姜、益智规范化栽培技术[M].广州:广东科技出版社,2003.38-39.
[55]国家药典委员会编.中华人民共和国药典2005年版一部[M].北京:化学工业出版社.2005.204-205.
[56]谭睿,陈士林,杨大坚.GC-MS分析益智挥发油透大鼠血脑屏障的成分研究[J].中草药,2004,35(6):624-625.
[57]GB 5461-2000食用盐[S].
[58]GB/T 13025.6-1991制盐工业通用实验方法氯离子的测定[S].
[59]吴育良,周志航.用氯离子选择电极同时分析水中Cl~-、Br~-、I~-的含量[J].分析试验室.1994,13(4):56-58.
[60]王卫星,郭朝晖,张玉萍.饮用水中氯化物的氯离子选择电极测定法[J].环境与健康杂志,2003,20(3):172-173.
[1]中医研究院中药研究所.历代中药炮制资料辑要[M].北京:内部出版,1973.
[2]王孝涛.关于对中药炮制历史沿革研究的看法[J].中国中药杂志,1992,17(4):211-212.
[3](唐)蔺道人.仙授理伤续断秘方[M].北京:人民卫生出版社,1957.
[4](宋)王怀隐,陈昭遇,等.太平圣惠方(上、下册)[M].北京:人民卫生出版社,1958.
[5](宋)洪遵著,宋咏梅等点校.洪氏集验方[M].上海:上海科学技术出版社,2003.
[6](宋)齐仲甫著,宋咏梅等点校.女科百问[M].天津:天津科学技术出版社,1999.
[7](宋)许叔微.普济本事方[M].上海:上海科学技术出版社,1959.
[8](元)王好古著,崔扫麈等点校.汤液本草[M].北京:人民卫生出版社,1987.
[9](元)危亦林著,王育学等校注.世医得效方[M].北京:中国中医药出版社,1996.
[10](元)罗天益.卫生宝鉴[M].北京:人民卫生出版社,1987.
[11](明)陈嘉谟.本草蒙筌[M].北京:人民卫生出版社,1988.
[12](明)朱棣.普济方[M].北京:人民卫生出版社,1959.
[13](明)刘文泰.本草品汇精要[M].北京:人民卫生出版社,1982.
[14](明)缪希雍.炮炙大法[M].北京:人民卫生出版社,1956.
[15](明)董宿辑录,(明)方贤续补,可嘉校注.奇效良方[M].北京:中国中医药出版社,1995.
[16](明)戴原礼著,才维秋等校注.秘传证治要诀及类方[M].北京:中国中医药出版社,1998.
[17](明)王肯堂著,吴唯等校注.证治准绳[M].北京:中国中医药出版社,1997.
[18](明)李时珍著,张守康等主校.本草纲目[M].北京:中国中医药出版社,1998.
[19](明)宋林皋.宋氏女科秘书[M].北京:中医书局,1955.
[20](明)李中梓著,王卫等点校.医宗必读[砌.天津:天津科学技术出版社,1999.
[21](明)龚廷贤撰,袁钟点校.寿世保元[M].大连:辽宁科学技术出版社,1997.
[22](明)王节斋集,薛已注.明医杂录[M].上海:大成书局《薛氏医案》石印本,1922.
[23](明)张浩.仁术便览[M].北京:商务印书馆,1957.
[24](明)张介宾.景岳全书[M].北京:中国中医药出版社,1994.
[25](明)武之望著,李明廉主校.济阴纲目[M].北京:人民卫生出版社,1996.
[26](清)陈修园.女科要旨[M].北京:人民卫生出版社,1982.
[27](清)蒋示吉著,王道瑞等校.医宗说约[M].北京:中国中医药出版社,2004.
[28](清)刘若金.本草述[M].北京:北京出版社,2000.
[29](清)杨时泰.本草述钩元[M].北京:科技卫生出版社,1958.
[30](清)黄元御著,麻瑞亭等点校.黄元御医书十一种--玉楸药解[M].北京:人民卫生出版社,1990.
[31](清)郭佩兰.本草汇[M].北京:北京出版社,2000.
[32](清)姚球.本草经解要[M].上海:上海古籍出版社,1996.
[33](清)陈复正著,图娅点校.幼幼集成[M].大连:辽宁科学技术出版社,1997.
[34](清)吴仪洛著,朱建平等点校.本草从新[M].北京:中医古籍出版社,2001.
[35](清)严西亭等著.得配本草[M].上海:上海科学技术出版社,1958.
[36](清)凌奂.本草害利[M].北京:中医古籍出版社,1982.
[37](清)张璐.本经逢原[M].北京:中国中医药出版社,2007.
[38](清)黄宫绣.本草求真[M].北京:人民卫生出版社,1987.
[39](清)汪昂著,张莉莎点校.医方集解[M].大连:辽宁科学技术出版社,1997.
[40](清)吴瑭著,李宗一等校注.吴鞠通医案[M].北京:中国中医药出版社,1998.
[41]中华人民共和国卫生部药典委员会.中华人民共和国药典1963年版一部[M].北京:人民卫生出版社,1964.
[42]中华人民共和国卫生部药典委员会.中华人民共和国药典一九七七年版一部[M].北京:人民卫生出版社,1978.
[43]中华人民共和国卫生部药典委员会.中华人民共和国药典一九八五年版一部[M].北京:人民卫生出版社、化学工业出版社,1985.
[44]中华人民共和国药政管理局.全国中药炮制规范1988年版[M].北京:人民卫生出版社, 1988.
[45]山东省卫生厅.山东省中药炮制规范一九九0年版[M].济南:山东科学技术出版社,1991.
[46]江西省卫生厅药政管理局.江西省中药炮制规范1991年版[M].上海:上海科学技术出版社,1991.
[47]吉林省卫生厅编.吉林省中药炮制标准(1986)[M].长春:吉林科学技术出版社出版。1987.
[48]庞国兴,金传山,江黎,等.益智炮制的初步研究[J].中成药.1994,16(5):21-22.
[49]张宏扬,益智取仁的新方法[J].中成药.1985,7:47-47.
[50]赵士凯.黄有云.益智仁的传统炮制及其工艺选择[J].中成药.1994,16(3);24-25.
[51]李贞汉,蔡月英.益智仁炮制新法[J].福建中医药.1995,26(4):24-24.
[52]刘赞清.益智仁去壳新法[J]。中药材.1990,13(12):48-49.
© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号 地址：北京市海淀区学院路29号 邮编：100083 电话：办公室：(+86 10)66554848；文献借阅、咨询服务、科技查新：66554700 |